The director of ‘The End’ discusses getting tips from Werner Herzog and how contemplating catastrophe can make us more human ...

Christopher Nolan’s Oppenheimer was that rare movie that was both a box office hit and a serious award winner. It also had ...

Oppenheimer started coverage on shares of Quince Therapeutics (NASDAQ:QNCX – Free Report) in a report released on Monday, ...

Oppenheimer said on Wednesday it no longer expects growth in U.S. investment banking revenue this year and slashed its ...

In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Terns Pharmaceuticals (TERN – Research Report), with a price ...

Such an advance, leaders agree, would fundamentally transform society. Google CEO Sundar Pichai has repeatedly described AI ...

Oppenheimer called the expected M&A rebound under the Trump administration “delayed or cancelled” and downgraded to "perform" ...

U.S. brokerage Oppenheimer downgraded Goldman Sachs, Jefferies Financial and Carlyle on Wednesday, citing a threat to ...

Oppenheimer lowered shares of Opthea (NASDAQ:OPT – Free Report) from an outperform rating to a market perform rating in a research report released on Monday, MarketBeat reports. A number of other ...

Christopher Nolan believes in staying true to the artist's spirit, and that is what we can expect from The Odyssey, his first foray into the mythological world.

Lam Research (NASDAQ:LRCX) received an Outperform rating as financial services firm Oppenheimer initiated coverage of the ...